Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.75 |
| ▸ | RAB9A | P51151 | 4/20 | 0.75 |
| ▸ | HPGD | P15428 | 3/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.72 |
| ▸ | LMNA | P02545 | 4/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.67 |
| ▸ | PGR | P06401 | 2/20 | 0.67 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.67 |
| ▸ | PDE4A | P27815 | 1/20 | 0.67 |
| ▸ | HRH1 | P35367 | 1/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.67 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.67 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.67 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.64 |
| ▸ | AR | P10275 | 1/20 | 0.64 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4-Methoxysalicylic Acid SCHEMBL3212873 | 0.98 | NPC1 (0.72) | NPC1RAB9AHPGDALDH1A1MAPK1 | |
| 4-Methoxysalicylic Acid SCHEMBL15271279 | 0.98 | NPC1 (0.72) | NPC1RAB9AHPGDALDH1A1MAPK1 | |
| 4-Methoxysalicylic Acid SCHEMBL3212855 | 0.98 | NPC1 (0.72) | NPC1RAB9AHPGDALDH1A1MAPK1 | |
| 4-Methoxysalicylic Acid SCHEMBL30490367 | 0.98 | NPC1 (0.72) | NPC1RAB9AHPGDALDH1A1MAPK1 | |
| 4-Methoxysalicylic Acid SCHEMBL15271283 | 0.98 | NPC1 (0.72) | NPC1RAB9AHPGDALDH1A1MAPK1 | |
| 4-Methoxysalicylic Acid SCHEMBL30179513 | 0.98 | NPC1 (0.72) | NPC1RAB9AHPGDALDH1A1MAPK1 | |
| SCHEMBL10596186 | 0.89 | NPC1 (0.61) | NPC1RAB9AHPGDALDH1A1MAPK1 | |
| SCHEMBL29365072 | 0.86 | NPC1 (1.00) | NPC1RAB9AHPGDALDH1A1MAPK1 | |
| SCHEMBL38652 | 0.86 | NPC1 (1.00) | NPC1RAB9AHPGDALDH1A1MAPK1 | |
| SCHEMBL1514997 | 0.86 | NPC1 (1.00) | NPC1RAB9AHPGDALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1894 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122031539-A | Pine bark polyphenol extract and preparation method and application thereof | 北京农学院 | 2026-05-15 | — | — | CN | claimed |
| CN-122005693-A | Application of Jiaweidanzhi Xiaoyao powder or extract thereof in preparation of medicines for treating depression complicated with ulcerative colitis | 河南中医药大学 | 2026-05-12 | — | — | CN | claimed |
| US-20260092029-A1 | LIGAND-ENABLED SCALABLE C-H HYDROXYLATION OF BENZOIC AND PHENYLACETIC ACIDS AT ROOM TEMPERATURE | SCRIPPS RESEARCH INST (US) | 2026-04-02 | — | — | US | claimed |
| US-20260002924-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2026-01-01 | — | — | US | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| US-12383476-B2 | W/O/W emulsion composition | SHISEIDO COMPANY, LTD. (JP) | 2025-08-12 | — | — | US | claimed |
| EP-4584236-A1 | LIGAND-ENABLED SCALABLE C-H HYDROXYLATION OF BENZOIC AND PHENYLACETIC ACIDS AT ROOM TEMPERATURE | The Scripps Research Institute (US) | 2025-07-16 | — | — | EP | claimed |
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | claimed |
| CN-118880486-B | Cool polyester fiber and preparation method thereof | 江苏恒科新材料有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-119591965-B | Heat-resistant polyethylene material and preparation method thereof | 北京市科学技术研究院 | 2025-05-16 | — | — | CN | claimed |
| WO-2003077861-A2 | WATER-BASED DELIVERY SYSTEMS | COLLAGENEX PHARMACEUTICALS, INC. (US) | 2003-09-25 | — | — | WO | claimed |
| US-20030130300-A1 | Respiratory system disorders; synergistic mixtures | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2003-07-10 | — | — | US | claimed |
| WO-2003024452-A1 | NOVEL MEDICAMENTS FOR INHALATION | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2003-03-27 | — | — | WO | claimed |
| US-20020128310-A1 | MEDICAL COMPOSITION AND USE THEREOF FOR THE MANUFACTURE OF A TOPICAL BARRIER FORMULATION, A UV-RADIATION ABSORBING FORMULATION, OR AN ANTIVIRAL, ANTIFUNGAL, OR ANTIINFLAMMTORY FORMULATION | NOVISCENS AB (SE) | 2002-09-12 | — | — | US | claimed |
| EP-0957927-A1 | MEDICAL COMPOSITION AND USE THEREOF FOR THE MANUFACTURE OF A TOPICAL BARRIER FORMULATION, A UV-RADIATION ABSORBING FORMULATION, OR AN ANTIVIRAL, ANTIFUNGAL, OR ANTIINFLAMMATORY FORMULATION | Noviscens AB (SE) | 1999-11-24 | — | — | EP | claimed |
| EP-0534817-B1 | Esterification process of salts of carboxylic acids | RHODIA CHIMIE SA (FR) | 1998-12-09 | — | — | EP | claimed |
| WO-1998026788-A1 | MEDICAL COMPOSITION AND USE THEREOF FOR THE MANUFACTURE OF A TOPICAL BARRIER FORMULATION, A UV-RADIATION ABSORBING FORMULATION, OR AN ANTIVIRAL, ANTIFUNGAL, OR ANTIINFLAMMATORY FORMULATION | NOVISCENS AB (SE) | 1998-06-25 | — | — | WO | claimed |
| EP-0539274-B1 | Method for the synthesis of aldehydes and of their derivatives | RHONE POULENC CHIMIE (FR) | 1996-04-10 | — | — | EP | claimed |
| US-4141774-A | METHOXYMETHYLATED NYLON TERPOLYMER | DAICEL LTD. (JP) | 1979-02-27 | — | — | US | claimed |
| US-3932340-A | ACID CATALYSTS | DAICEL LTD. (JA) | 1976-01-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092029-A1 | LIGAND-ENABLED SCALABLE C-H HYDROXYLATION OF BENZOIC AND PHENYLACETIC ACIDS AT ROOM TEMPERATURE | CYP2B6, CYP2A6, CYP1A1 | NPC1 3490/4885RAB9A 4623/4885HPGD 110/4885 |
| US-20260002924-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | FGB, NR4A1, CYP2E1 | NPC1 1136/4885RAB9A 4242/4885HPGD 2585/4885 |
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | HSD17B7, HSD17B12, BCKDK | NPC1 2341/4885RAB9A 4512/4885HPGD 441/4885 |
| US-20030130300-A1 | Respiratory system disorders; synergistic mixtures | ADRB3, ADRB1, CHRM3 | NPC1 3159/4885RAB9A 651/4885HPGD 1091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.